UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 6, 2026
Sale
Calculated transaction value
$196.79K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 5, 2026
Public filing date
Oct 6, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$536.4
Oct 5, 2026
First close after public filing
$545
Oct 7, 2026
Return after filing · so far
+0.94%
Through Oct 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 360 shares @ $546.63
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000157
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.26M
Buys / sales
0 / 11
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 5, 2026 | $268.67K |
| United Therapeutics Corp UTHR | Sale | Oct 5, 2026 | $486.37K |
| United Therapeutics Corp UTHR | Sale | Oct 5, 2026 | $555.63K |
| United Therapeutics Corp UTHR | Sale | Oct 5, 2026 | $425.59K |
| United Therapeutics Corp UTHR | Sale | Oct 5, 2026 | $686.19K |
| United Therapeutics Corp UTHR | Sale | Oct 5, 2026 | $352.8K |
| United Therapeutics Corp UTHR | Sale | Oct 5, 2026 | $671.12K |
| United Therapeutics Corp UTHR | Sale | Oct 5, 2026 | $502.28K |
| United Therapeutics Corp UTHR Current | Sale | Oct 5, 2026 | $196.79K |
| United Therapeutics Corp UTHR | Exercise | Oct 5, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Oct 5, 2026 | $498.07K |
| United Therapeutics Corp UTHR | Exercise | Oct 5, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 5, 2026 | $502.04K |